Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Addressing intracellular Amyloidosis in bacteria with RepA-WH1, a prion-like protein

  • Molina-García, Laura
  • Gasset-Rosa, F.
  • Moreno-del Álamo, María
  • Moreno Díaz de la Espina, Susana
  • Giraldo, R.
25 p.-1 fig. This is a pre-print of an article published in Methods in Molecular Biology. The final authenticated version is available online at: https://doi.org/10.1007/978-1-4939-7816-8_18, Bacteria are the simplest cellular model in which amyloidosis has been addressed. It is well documented that bacterial consortia (biofilms) assemble their extracellular matrix on an amyloid scaffold, yet very few intracellular amyloids are known in bacteria. Here, we describe the methods we have resorted to characterize in Escherichia coli cells the amyloidogenesis, propagation, and dynamics of the RepA-WH1 prionoid. This prion-like protein, a manifold domain from the plasmid replication protein RepA, itself capable of assembling a functional amyloid, causes when expressed in E. coli a synthetic amyloid proteinopathy, the first model for an amyloid disease with a purely bacterial origin. These protocols are useful to study other intracellular amyloids in bacteria., This research has been supported by a grant from Spanish AEI/EU-FEDER (BIO2015-68730-R), No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Optogenetic navigation of routes leading to protein amyloidogenesis in bacteria

  • Giraldo, R.
32 p.-1 graph. abst.-7 fig.-8 fig.supl., Modulation of liquid–liquid and liquid–hydrogel phase transitions is central to avoid the cytotoxic aggregation of proteins in eukaryotic cells, but knowledge on its relevance in bacteria is limited. Here the power of optogenetics to engineer proteins as light-responsive switches has been used to control the balance between solubility and aggregation for LOV2–WH1, a chimera between the plant blue light-responsive domain LOV2 and the bacterial prion-like protein RepA-WH1. These proteins were first linked by fusing, as a continuous α-helix, the C-terminal photo-transducer Jα helix in LOV2 with the N-terminal domain-closure α1 helix in RepA-WH1, and then improved for light-responsiveness by including mutations in the Jα moiety. In the darkness and in a crowded solution in vitro, LOV2–WH1 nucleates the irreversible assembly of amyloid fibers into a hydrogel. However, under blue light illumination, LOV2–WH1 assembles as soluble oligomers. When expressed in Escherichia coli, LOV2–WH1 forms in the darkness large intracellular amyloid inclusions compatible with bacterial proliferation. Strikingly, under blue light, LOV2–WH1 aggregates decrease in size, while they become detrimental for bacterial growth. LOV2–WH1 optogenetics governs the assembly of mutually exclusive inert amyloid fibers or cytotoxic oligomers, thus enabling the navigation of the conformational landscape of protein amyloidogenesis to generate potential photo-activated anti-bacterial devices (optobiotics)., This work has been financed with grants from the Spanish AEI (BIO2012-30852 and BIO2015-68730-R)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A partner-switching system controls activation of mixed-linkage β-glucan synthesis by c-di-GMP in Sinorhizobium meliloti

  • Baena, Irene
  • Pérez-Mendoza, Daniel
  • Sauviac, L.
  • Francesch, K.
  • Martín, Marta
  • Rivilla, Rafael
  • Bonilla, Ildefonso
  • Bruand, C.
  • Sanjuán, Juan
  • Lloret, Javier
Sinorhizobium meliloti synthesizes a linear mixed-linkage (1 → 3)(1 → 4)-β-d-glucan (ML β-glucan, MLG) in response to high levels of cyclic diguanylate (c-di-GMP). Two proteins BgsA and BgsB are required for MLG synthesis, BgsA being the glucan synthase which is activated upon c-di-GMP binding to its C-terminal domain. Here we report that the product of bgrR (SMb20447) is a diguanylate cyclase (DGC) that provides c-di-GMP for the synthesis of MLG by BgsA. bgrR is the first gene of a hexacistronic bgrRSTUWV operon, likely encoding a partner-switching regulatory network where BgrR is the final target. Using different approaches, we have determined that the products of genes bgrU (containing a putative PP2C serine phosphatase domain) and bgrW (with predicted kinase effector domain), modulate the phosphorylation status and the activity of the STAS domain protein BgrV. We propose that unphosphorylated BgrV inhibits BgrR DGC activity, perhaps through direct protein–protein interactions as established for other partner switchers. A bgrRSTUWV operon coexists with MLG structural bgsBA genes in many rhizobial genomes but is also present in some MLG non-producers, suggesting a role of this partner-switching system in other processes besides MLG biosynthesis., This work was supported by Grants BIO2014-55075-P, BIO2017-83533-P and BIO2015-64480/R MINECO/FEDEREU. I.B. was supported by a Ministerio de Educación FPU fellowship (AP2010-0811). DPM was supported by Andalucía Talent Hub Program launched by the Andalusian Knowledge Agency, co-funded by the European Union’s Seventh Framework Program, Marie Skłodowska-Curie actions (COFUND –Grant Agreement no. 291780) and the Ministry of Economy Innovation, Science and Employment of the Junta de Andalucía, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Variation in predicted COVID-19 risk among lemurs and lorises, Strepsirrhine ACE2 variation

  • Melin, Amanda D.
  • Orkin, Joseph D.
  • Janiak, Mareike C.
  • Valenzuela, Alejandro
  • Kuderna, Lukas F. K.
  • Marrone, Frank
  • Ramangason, Hasinala
  • Horvath, Julie E.
  • Roos, Christian
  • Kitchener, Andrew C.
  • Khor, Chiea Chuen
  • Lim, Weng Khong
  • Lee, Jessica G. H.
  • Tan, Patrick
  • Umapathy, Govindhaswamy
  • Raveendran, Muthuswamy
  • Harris, R. Alan
  • Gut, Ivo
  • Gut, Marta
  • Lizano, Esther
  • Nadler, Tilo
  • Zinner, Dietmar
  • Johnson, Steig E.
  • Jarvis, Erich D.
  • Fedrigo, Olivier
  • Wu, Dongdong
  • Zhang, Guojie
  • Farh, Kyle Kai-How
  • Rogers, Jeffrey
  • Marqués-Bonet, Tomàs
  • Navarro, Arcadi
  • Juan, David
  • Arora, Paramjit S.
  • Higham, James P.
Versión editorial disponible en: http://hdl.handle.net/10261/239013, The novel coronavirus SARS-CoV-2, which in humans leads to the disease COVID-19, has caused global disruption and more than 1.5 million fatalities since it first emerged in late 2019. As we write, infection rates are currently at their highest point globally and are rising extremely rapidly in some areas due to more infectious variants. The primary viral target is the cellular receptor angiotensin-converting enzyme2 (ACE2). Recent sequence analyses of the ACE2 gene predicts that many nonhuman primates are also likely to be highly susceptible to infection. However, the anticipated risk is not equal across the Order. Furthermore, some taxonomic groups show high ACE2 amino acid conservation, while others exhibit high variability at this locus. As an example of the latter, analyses of strepsirrhine primate ACE2 sequences to date indicate large variation among lemurs and lorises compared to other primate clades despite low sampling effort. Here, we report ACE2 gene and protein sequences for 71 individual strepsirrhines, spanning 51 species and 19 genera. Our study reinforces previous results and finds additional variability in other strepsirrhine species, and suggests several clades of lemurs have high potential susceptibility to SARS-CoV-2 infection. Troublingly, some species, including the rare and Endangered aye-aye (Daubentonia madagascariensis), as well as those in the genera Avahi and Propithecus, may be at high risk. Given that lemurs are endemic to Madagascar and among the primates at highest risk of extinction globally, further understanding of the potential threat of COVID-19 to their health should be a conservation priority. All feasible actions should be taken to limit their exposure to SARS-CoV-2., ADM is supported by the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery Grant) and Canada Research Chairs Program. MCJ’s postdoctoral appointment is supported by funding from the Natural Environment Research Council (NERC NE/T000341/1). IG and MG acknowledge the support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III and the 2014–2020 Smart Growth Operating Program, to the EMBL partnership and cofinancing with the European Regional Development Fund (MINECO/FEDER, BIO2015-71792-P). We also acknowledge the support of the Centro de Excelencia Severo Ochoa, and the Generalitat de Catalunya through the Departament de Salut, Departament d’Empresa i Coneixement and the CERCA Programme. TMB is supported by funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No. 864203), BFU2017-86471-P (MINECO/FEDER, UE), “Unidad de Excelencia María de Maeztu”, funded by the AEI (CEX2018-000792-M), Howard Hughes International Early Career, Obra Social "La Caixa" and Secretaria d’Universitats i Recerca and CERCA Programme del Departament d’Economia i Coneixement de la Generalitat de Catalunya (GRC 2017 SGR 880). PSA thanks the National Institutes of Health (R35GM130333) for financial support. E.L is supported by CGL2017- 82654-P (MINECO/FEDER,UE). EDJ and OF's contributions were supported by funds from Howard Hughes Medical Institute and the Rockefeller University. Chris Smith drew the images for Figure 1. The authors would like to thank the Veterinary and Zoology staff at Wildlife Reserves Singapore for their help in obtaining the tissue samples, as well as the Lee Kong Chian Natural History Museum for storage and provision of the tissue samples., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Functional implementation of a linear glycolysis for sugar catabolism in Pseudomonas putida

  • Sánchez-Pascuala, Alberto
  • Fernández-Cabezón, Lorena
  • Lorenzo, Víctor de
  • Nikel, Pablo I.
The core metabolism for glucose assimilation of the soil bacterium and platform strain Pseudomonas putida KT2440 has been reshaped from the native, cyclically-operating Entner-Doudoroff (ED) pathway to a linear Embden-Meyerhof-Parnas (EMP) glycolysis. The genetic strategy deployed to obtain a suitable host for the synthetic EMP route involved not only eliminating enzymatic activities of the ED pathway, but also erasing peripheral reactions for glucose oxidation that divert carbon skeletons into the formation of organic acids in the periplasm. Heterologous glycolytic enzymes, recruited from Escherichia coli, were genetically knocked-in in the mutant strain to fill the metabolic gaps for the complete metabolism of glucose to pyruvate through a synthetic EMP route. A suite of genetic, physiological, and biochemical tests in the thereby-refactored P. putida strain—which grew on glucose as the sole carbon and energy source—demonstrated the functional replacement of the native sugar metabolism by a synthetic catabolism. 13C-labelling experiments indicated that the bulk of pyruvate in the resulting strain was generated through the metabolic device grafted in P. putida. Strains carrying the synthetic glycolysis were further engineered for carotenoid synthesis from glucose, indicating that the implanted EMP route enabled higher carotenoid content on biomass and yield on sugar as compared with strains running the native hexose catabolism. Taken together, our results highlight how conserved metabolic features in a platform bacterium can be rationally reshaped for enhancing physiological traits of interest., This study was supported by grants from The Novo Nordisk Foundation (grant NNF10CC1016517, and LiFe, NNF18OC0034818) and the Danish Council for Independent Research (SWEET, DFF-Research Project 8021-00039B) to P.I.N. and by the HELIOS Project of the Spanish Ministry of Science BIO 2015-66960-C3-2-R (MINECO/FEDER), the ARISYS (ERC-2012-ADG-322797), EmPowerPutida (EU-H2020-BIOTEC-2014-2015-6335536), MADONNA (H2020-FET-OPEN-RIA-2017-1-766975), BioRoboost (H2020-NMBP-BIO-CSA-2018), and SYNBIO4FLAV (H2020-NMBP/0500) Contracts of the European Union and the S2017/BMD-3691 InGEMICS-CM funded by the Comunidad de Madrid (Spain) and the European Structural and Investment Funds. L.F.C. is supported by the European Union's Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie grant 713683 (COFUNDfellowsDTU).